
Find your way through EMA
We monitor and register applications from pharmaceutical companies to the European Medicines Agency (EMA). Both applications for marketing licences for new pharmaceuticals, as well as applications for major changes to existing marketing authorisations such as extensions of indications and other extensions.
It can be difficult to understand the regulatory procedures in the European Medicines Agency (EMA). Therefore, as a service for our stakeholders we have prepared a guide to the European Medicines Agency (EMA), which we call "Navigating the EMA” . You can read the complete guide or use it for reference.
Read more
Horizon Scanning
Amgros works systematically to establish an overview of the future opportunities for pharmaceuticals treatments
READ MOREPipeline meetings
Pipeline meetings with pharmaceutical companies are an important source of information, when Horizon Scanning forecasts the future drugs on the Danish market
READ MOREPharmaceuticals in the pipeline in the EMA
We monitor and register applications from pharmaceutical companies to the European Medicines Agency (EMA): Both applications for marketing authorisations for new pharmaceuticals, as well as applications for changes to existing marketing authorisations such as extensions of indications and other extensions.
READ MORELatest news
If you would like to receive news from Amgros directly in your inbox, sign up for our newsletter. You can choose between general news or the latest news from Horizon Scanning.
SIGN UPContact

Helle Bräuner
Team manager
I’m responsible for building up and developing Horizon Scanning at Amgros. We spot all new pharmaceuticals on their way to Denmark. And we have particular focus on hospital pharmaceuticals